Novartis Halts 8 CAR-T Trials After 3 Patient Deaths

1. 1Novartis (NVS) has halted eight clinical trials of its experimental CAR-T therapy.
2. 2Three patient deaths were confirmed in late August across trials for autoimmune and neurological diseases.
3. 3An investigation into the link between the deaths and the drug continues, also affecting Bristol Myers Squibb and others.

Source Barrons.com +1 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →